Every baby's DNA ‘to be screened' on the NHS in bid to detect and prevent disease
All babies could have their DNA mapped to test for future illnesses under a plan unveiled by the government, it has been reported.
Labour is set to pour £650 million into DNA technology in an effort to treat serious illnesses before they become a problem.
In comments first reported in the Daily Telegraph, health secretary Wes Streeting said new technology in areas such as genomics would help 'leapfrog' illnesses.
The outlet says, within a decade, every baby will undergo whole genome sequencing as part of the drive.
The investment in genomics is expected to support the Government's 10-year plan for the NHS, which will see a greater focus on technology and prevention.
Mr Streeting said: 'The revolution in medical science means that we can transform the NHS over the coming decade, from a service which diagnoses and treats ill health to one that predicts and prevents it.
'Genomics presents us with the opportunity to leapfrog disease, so we're in front of it rather than reacting to it.'
Mr Streeting has previously spoken about his desire to make the NHS more preventative, reducing rates of serious illness and saving money in the process.
The plan is also likely to see a greater role for artificial intelligence and other technologies to predict illness and allow treatment or medication to be offered much earlier.
He added: 'With the power of this new technology, patients will be able to receive personalised healthcare to prevent ill health before symptoms begin, reducing the pressure on NHS services and helping people live longer, healthier lives.'
Along with a greater focus on prevention, the Government's 10-year plan is expected to include Mr Streeting's two other 'shifts' in the NHS.
That will see a shift away from hospitals towards more community-focused care, and from analogue to digital services.
It follows Chancellor Rachel Reeves' announcement that the Government would increase NHS funding by £29 billion per year in real terms over the next three years as it tries to cut waiting lists in line with its election promises.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
20 minutes ago
- Daily Mail
How to STOP taking HRT: You're not supposed to take it indefinitely and coming off can be life-changing. Now DR ELLIE CANNON reveals the dangers - and how to know if it's time to quit
It's hard to overstate the revolution that has occurred in menopause treatment over the past decade. In the UK, it is thought that about 13 million women are, at any one time, experiencing the distinctive midlife issues – including low mood, anxiety, hot flushes and difficulty sleeping.
Times
30 minutes ago
- Times
A robot surgeon? I'll put my money on that
T hank you for waiting, the robot will see you now. Nine in ten keyhole operations won't need a human surgeon in the room within the next decade, according to the NHS. One in five operations are already carried out by robots, guided remotely, to improve outcomes while cutting costs. Science fiction is becoming surgical fact because robotic-assisted surgery can mean smaller incisions, reduced scarring and quicker recovery. There's no need to take my word for it: Sir Jim Mackey, the chief executive of the NHS, said: 'We are using every tool to ensure patients get the best possible treatment. Expanding the use of new tech, such as robotic surgery, will play a huge part.' Wes Streeting, the health and social care secretary, added: 'I know how important this is. The NHS saved my life from kidney cancer with an operation led by a world-class surgeon being helped by a robot.'
Daily Mail
40 minutes ago
- Daily Mail
Revealed: The Brits who need Viagra the most - as NHS figures show which areas show biggest demand for erectile dysfunction drug
New NHS figures have revealed which areas have the highest demand for Viagra. Men from Yorkshire are given the most prescriptions for Viagra or similar performance-aiding drugs. The East Riding of Yorkshire topped the table with 3.5 per cent of people needing the little blue pill. Coming in at a close second was Northumberland with 3.3 per cent of men using the pill. And in the coastal area of Dorset, which is popular with retirees, 3.2 per cent of men required the pill. On top of that men in the North used Viagra more often that men in the South last year. Those living in London, Cambridgeshire and Berkshire were far less likely to ask for a prescription. But only 1.5 per cent of men in Leicester were prescribed the drug - making it the area with the lowest rate of users in the UK. Consultant urologist Gordon Muir, of London Bridge Hospital, told the Sun: 'NHS provision of this treatment can vary from region to region, as can the ratio of underlying disease which probably explains some of the differences.' Most men occasionally struggle to get or keep an erection due to stress, tiredness, anxiety or drinking too much alcohol. But up to one in five men in the UK (4.3million) suffer erectile dysfunction - when this keeps happening. It can be caused by high blood pressure or cholesterol, hormone problems or side effects from medication. Medicines containing sildenafil, originally developed to treat angina, are often used to treat the condition. It expands blood vessels and boosts blood flow to the genitals. Viagra was originally cooked up by Covid vaccine manufacturer Pfizer in 1989, with hopes that sildenafil citrate could treat high blood pressure. But clinical trials in Wales a few years later saw men report an unusual side effect —they got more erections while taking the medication. The drug was approved in the US and EU in 1998, branded as Viagra, and became one of the fastest selling drugs of all time. Nearly half of men between the ages of 40 and 70 suffer from erectile dysfunction in the UK - this is around 4.3 million people. But reports suggest the 'little blue pill' is now becoming increasingly popular with younger individuals in their twenties and thirties. A 2020 survey of 5,000 people carried out for Upjohn, the maker of Viagra Connect, the over-the-counter version of the drug, showed that 18 per cent of 18-24-year-old men had erection difficulties. And more recently, the ease of getting the drug without a prescription seems to be fueling its popularity with a younger audience. Non-branded sildenafil can be available from the NHS, to treat erectile dysfunction or pulmonary hypertension.
